Results 241 to 249 of about 28,797 (249)

Recombinant human C1 esterase inhibitor for prophylaxis of hereditary angio-oedema: a phase 2, multicentre, randomised, double-blind, placebo-controlled crossover trial

Lancet, The, 2017
Marc A Riedl, Avner Reshef, Sladjana Andrejevic   +2 more
exaly  

Cyclin-Dependent Kinase Inhibitor 2A (CDKN2A/P16) Polymorphisms and Risk of Pancreatic Neuroendocrine Tumors

2015
Campa, D., Rizzato, C., Capurso, G., Delle Fave, G., Gazouli, M., Landi, S., Buechler, M. W., Małecka Panas, E., Boggi, U., Andriulli, A., Scarpa, A., PASQUALI, CLAUDIO, Canzian, F.   +12 more
openaire   +2 more sources

The discovery and development of rivaroxaban, an oral, direct factor Xa inhibitor

Nature Reviews Drug Discovery, 2010
exaly  

Marrow Plasma Cell Immunohistochemical Expression Profiles of Cyclins (A, D1, D2, D3), Cyclin Dependent Kinase Inhibitors (p16, p21) and Ki67: Predictors of Survival in Patients with Multiple Myeloma.

, 2005
Meral Beksaç, Ender Soydan, Selami Koçak Toprak, Merih Çakar Kızıl, Gülşah Kaygusuz, Işınsu Kuzu   +5 more
openalex   +1 more source

HUMAN ARTERIAL AND VENOUS TISSUES GENERATE PROSTACYCLIN (PROSTAGLANDIN X), A POTENT INHIBITOR OF PLATELET AGGREGATION

Lancet, The, 1977
exaly  

Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure

Lancet, The, 1992
exaly  

Acute myeloid leukemia management and research in 2025

Ca-A Cancer Journal for Clinicians
exaly  

A proton-pump inhibitor expedition: the case histories of omeprazole and esomeprazole

Nature Reviews Drug Discovery, 2003
exaly  

Co-localization of EBV and Expression of P16- Cyclin-Dependent Kinase inhibitor Protein in Tissues from Patients with Non- Hodgkin's Lymphoma

, 2016
Shakir H. Mohammed Al-Alwany, Saad Hasan Mohammed Ali, Masar Riyadh Rashid AL-Mousawi   +2 more
openalex